Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500) (Q80791117)
Jump to navigation
Jump to search
scientific article published on 01 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500) |
scientific article published on 01 December 2007 |
Statements
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500) (English)
Cheryl L Willman
Frederick R Appelbaum
Stephen H Petersdorf
Cathryn Rankin
David R Head
Howard R Terebelo
Stanley P Balcerzak
Anand B Karnad